T1	PROC 46 65	ENSAYO DE EXTENSIÓN
T2	CHEM 93 103	ECULIZUMAB
#1	AnnotatorNotes T2	C1541483; eculizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	DISO 119 148	MIASTENIA GRAVIS GENERALIZADA
#2	AnnotatorNotes T3	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome
T4	PROC 203 244	ENSAYO DE EXTENSIÓN, ABIERTO, DE FASE III
T5	PROC 264 298	EVALUAR LA SEGURIDAD Y LA EFICACIA
#3	AnnotatorNotes T5	C0511730; Identify product efficacy and safety issues; Health Care Activity
T6	CHEM 302 312	ECULIZUMAB
#4	AnnotatorNotes T6	C1541483; eculizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	DISO 328 357	MIASTENIA GRAVIS GENERALIZADA
#5	AnnotatorNotes T7	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome
T8	DISO 413 429	Miastenia Gravis
#6	AnnotatorNotes T8	C0026896; Myasthenia Gravis; Disease or Syndrome
T9	DISO 456 485	MIASTENIA GRAVIS GENERALIZADA
#7	AnnotatorNotes T9	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome
T10	PROC 697 706	protocolo
#8	AnnotatorNotes T10	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T11	PROC 810 828	prueba de embarazo
#9	AnnotatorNotes T11	C0032976; Pregnancy Tests; Diagnostic Procedure
T12	CHEM 830 860	gonadotropina coriónica humana
#10	AnnotatorNotes T12	C1141639; human chorionic gonadotropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T13	CHEM 862 865	GCH
#11	AnnotatorNotes T13	C1141639; human chorionic gonadotropin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T14	ANAT 870 875	suero
#12	AnnotatorNotes T14	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T15	PROC 914 940	tratamiento anticonceptivo
T16	PROC 1024 1050	interrumpir el tratamiento
T17	DISO 1154 1183	AA relacionado con el fármaco
#13	AnnotatorNotes T17	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T18	CHEM 1176 1183	fármaco
#14	AnnotatorNotes T18	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T19	PROC 1546 1556	evaluación
#15	AnnotatorNotes T19	C1261322; Evaluation procedure; Health Care Activity
T20	PROC 169 180	TRATAMIENTO
#16	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	PROC 378 389	TRATAMIENTO
#17	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	PROC 830 875	gonadotropina coriónica humana [GCH] en suero
T23	ANAT 844 853	coriónica
#18	AnnotatorNotes T23	C0008503; Chorion; Embryonic Structure
T24	DISO 1352 1361	patología
#19	AnnotatorNotes T24	C0677042; Pathology processes; Pathologic Function
T25	DISO 150 153	MGg
T26	DISO 359 362	MGg
T27	PROC 587 623	consentimiento informado por escrito
#20	AnnotatorNotes T27	C0811741; Obtain informed written consent; Health Care Activity
T28	Date 13 17	2013
T29	LIVB 107 114	SUJETOS
#21	AnnotatorNotes T29	C0681850; Study Subject; Group
T30	LIVB 316 323	SUJETOS
#22	AnnotatorNotes T30	C0681850; Study Subject; Group
T31	LIVB 517 523	sujeto
#23	AnnotatorNotes T31	C0681850; Study Subject; Group
T32	LIVB 565 571	sujeto
#24	AnnotatorNotes T32	C0681850; Study Subject; Group
T33	LIVB 630 636	sujeto
#25	AnnotatorNotes T33	C0681850; Study Subject; Group
T34	Neg_cue 794 803	negativos
T35	LIVB 888 895	sujetos
#26	AnnotatorNotes T35	C0681850; Study Subject; Group
T36	Duration 1005 1012	5 meses
T37	LIVB 1085 1092	sujetos
#27	AnnotatorNotes T37	C0681850; Study Subject; Group
T38	LIVB 1396 1408	investigador
#28	AnnotatorNotes T38	C0035173; Research Personnel; Professional or Occupational Group
T40	LIVB 1453 1459	sujeto
#29	AnnotatorNotes T40	C0681850; Study Subject; Group
T41	LIVB 1513 1519	sujeto
#30	AnnotatorNotes T41	C0681850; Study Subject; Group
T42	LIVB 1564 1571	sujetos
#31	AnnotatorNotes T42	C0681850; Study Subject; Group
T43	PHYS 820 828	embarazo
#32	AnnotatorNotes T43	C0032961; Pregnancy; Organism Function
T44	PHYS 1222 1233	embarazadas
#33	AnnotatorNotes T44	C0032961; Pregnancy; Organism Function
T45	PHYS 1294 1305	embarazadas
#34	AnnotatorNotes T45	C0032961; Pregnancy; Organism Function
T46	Age 755 766	edad fértil
T47	PHYS 1249 1258	lactancia
#35	AnnotatorNotes T47	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T39	LIVB 738 751	participantes
#36	AnnotatorNotes T39	C4554048; Study Participant; Population Group
T48	LIVB 1198 1211	Participantes
#37	AnnotatorNotes T48	C4554048; Study Participant; Population Group
A1	Assertion T43 Negated
#38	AnnotatorNotes T25	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome
#39	AnnotatorNotes T26	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome
#40	AnnotatorNotes T22	C2208823; serum human chorionic gonadotropin (hCG); Laboratory Procedure 
#41	AnnotatorNotes T15	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
#42	AnnotatorNotes T16	C0850893; stop medication; Therapeutic or Preventive Procedure
T49	Spec_cue 1410 1417	pudiera
T50	CONC 1418 1428	interferir
A2	Assertion T50 Speculated
#43	AnnotatorNotes T50	C0521102; Interferes with; Functional Concept
T51	Observation 1435 1472	participación del sujeto en el ensayo
#44	AnnotatorNotes T51	C1278516; Patient participation status; Finding (?)
R1	Speculation Arg1:T49 Arg2:T50	
T52	Observation 1488 1494	riesgo
A3	Assertion T52 Speculated
R3	Speculation Arg1:T49 Arg2:T52	
T53	CONC 1530 1539	confusión
A4	Assertion T53 Speculated
R4	Speculation Arg1:T49 Arg2:T53	
T54	Observation 1272 1305	intención de quedarse embarazadas
#45	AnnotatorNotes T54	C0032992; Pregnancy, Planned; Finding
R5	Experiences Arg1:T48 Arg2:T44	
R6	Experiences Arg1:T48 Arg2:T47	
R8	Before Arg1:T54 Arg2:T45	
R9	Causes Arg1:T18 Arg2:T17	
R10	Experiences Arg1:T29 Arg2:T2	
T55	Quantifier_or_Qualifier 155 180	RESISTENTE AL TRATAMIENTO
#46	AnnotatorNotes T55	C0205269; Unresponsive to Treatment; Functional Concept
R11	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T55	
R12	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T55	
T56	Quantifier_or_Qualifier 364 389	RESISTENTE AL TRATAMIENTO
R13	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T56	
R14	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T56	
R15	Experiences Arg1:T30 Arg2:T7	
R16	Experiences Arg1:T30 Arg2:T6	
R17	Experiences Arg1:T30 Arg2:T26	
R18	Experiences Arg1:T29 Arg2:T3	
R19	Experiences Arg1:T29 Arg2:T25	
R20	Experiences Arg1:T29 Arg2:T20	
R21	Experiences Arg1:T30 Arg2:T21	
T57	Observation 527 547	completado el ensayo
#47	AnnotatorNotes T57	C2732579; Completion of clinical trial; Finding
T58	Observation 642 651	dispuesto
#48	AnnotatorNotes T58	C0600109; Willing; Finding
R23	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T58	
T59	Observation 657 706	capaz de cumplir con los requisitos del protocolo
R24	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T59	
R25	Has_Age Arg1:T39 Arg2:T46	
R26	Negation Arg1:T34 Arg2:T43	
R27	Experiences Arg1:T39 Arg2:T11	
R28	Location_of Arg1:T14 Arg2:T22	
R29	Experiences Arg1:T39 Arg2:T22	
R30	Experiences Arg1:T35 Arg2:T15	
R31	Has_Duration_or_Interval Arg1:T15 Arg2:T36	
R32	After Arg1:T15 Arg2:T16	
T60	PROC 990 996	ensayo
#49	AnnotatorNotes T60	C0008976; Clinical Trials; Research Activity
R33	Overlap Arg1:T15 Arg2:T60	
T61	Observation 1097 1118	se retiren del ensayo
#50	AnnotatorNotes T61	C0422727; Patient withdrawn from trial; Finding (?)
R35	Causes Arg1:T17 Arg2:T61	
R36	Experiences Arg1:T37 Arg2:T17	
T62	PROC 1332 1338	ensayo
#51	AnnotatorNotes T62	C0008976; Clinical Trials; Research Activity
R37	Overlap Arg1:T54 Arg2:T62	
R38	Overlap Arg1:T47 Arg2:T62	
R39	Overlap Arg1:T44 Arg2:T62	
R40	Experiences Arg1:T40 Arg2:T24	
R42	Before Arg1:T24 Arg2:T52	
R43	Experiences Arg1:T41 Arg2:T52	
R45	Experiences Arg1:T41 Arg2:T24	
R47	Experiences Arg1:T41 Arg2:T19	
R48	Experiences Arg1:T42 Arg2:T19	
R49	Experiences Arg1:T40 Arg2:T19	
R50	Experiences Arg1:T42 Arg2:T52	
R52	Experiences Arg1:T42 Arg2:T24	
#52	AnnotatorNotes T56	C0205269; Unresponsive to Treatment; Functional Concept
R53	Location_of Arg1:T14 Arg2:T11	
#53	AnnotatorNotes T52	C0559571; At risk; Finding
R22	Experiences Arg1:T39 Arg2:T43	
R7	Experiences Arg1:T48 Arg2:T45	
A5	Experiencer T31 Patient
A6	Experiencer T32 Patient
A7	Experiencer T33 Patient
A8	Experiencer T39 Patient
A9	Experiencer T35 Patient
A10	Experiencer T37 Patient
A11	Experiencer T48 Patient
A12	Experiencer T38 Other
A13	Experiencer T40 Patient
A14	Experiencer T41 Patient
A15	Experiencer T42 Patient
A16	Experiencer T29 Patient
A17	Experiencer T30 Patient
A18	Status T45 Future
T63	Result_or_Value 783 803	resultados negativos
R2	Has_Result_or_Value Arg1:T11 Arg2:T63	
